AI assistant
Sending…
Vanda Pharmaceuticals Inc. — Director's Dealing 2009
May 27, 2009
33390_dirs_2009-05-27_837679d7-29ce-4add-bf8e-5f442eec236a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Vanda Pharmaceuticals Inc. (VNDA)
CIK: 0001347178
Period of Report: 2009-05-22
Reporting Person: Polymeropoulos Mihael Hristos (Director, Chief Executive Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2009-05-22 | Employee Stock Option (Right to Buy) | $12.55 | A | 250000 | Acquired | 2019-05-21 | Common Stock (250000) | Direct |
Footnotes
F1: The option vests each month with respect to 2.0833% of the aggregate option share total.
More from Vanda Pharmaceuticals Inc.
Interim / Quarterly Report
2026
May 7
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Regulatory Filings
2026
Apr 22
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 24
Regulatory Filings
2026
Feb 23
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19